Literature DB >> 34748155

Abnormal [18F]fluorodeoxyglucose accumulation to tori tubarius in IgG4-related disease.

Ken Nagahata1, Masatoshi Kanda2, Ryuta Kamekura3,4, Masanari Sugawara1,5, Naoya Yama6, Chisako Suzuki1, Kenichi Takano3, Masamitsu Hatakenaka6, Hiroki Takahashi1.   

Abstract

OBJECTIVES: Tubarial glands (TGs) are recently refocused gland tissues localized near the tori tubarius in the nasopharynx and their clinical relevance is not clear yet. IgG4-related disease (IgG4-RD) is a progressive fibrosing condition and salivary glands are well-affected lesions. The aim of the present study is to examine [18F]fluorodeoxyglucose ([18F]FDG) accumulation to the tori tubarius in IgG4-related disease (IgG4-RD).
METHODS: 48 patients with IgG4-RD who underwent positron emission tomography (PET) scanning with [18F]FDG were included and semi-quantitative analysis of [18F]FDG accumulation to tori tubarius was performed along with the clinical features and histopathological analysis.
RESULTS: Of the 48 patients, abnormal [18F]FDG accumulation (metabolic tumour volume ≥ 1) to tori tubarius was observed in 15 (31.3%), all of whom had lesions in other head and neck glands. IgG4-RD patients with abnormal [18F]FDG accumulation to tori tubarius showed swollen nasopharyngeal walls around tori tubarius and forceps biopsy of the lesion revealed acinar cells and IgG4-positive plasma cells histologically. Abnormal [18F]FDG accumulation (maximum standard uptake value, metabolic tumour volume and total lesion glycolysis) to tori tubarius correlated with higher IgG4 and lower IgA serum concentrations.
CONCLUSIONS: Abnormal [18F]FDG accumulation to tori tubarius can be observed in patients with IgG4-RD and the abnormal [18F]FDG accumulation to tori tubarius can be a clue of TG involvement in IgG4-RD.
© 2021. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine.

Entities:  

Keywords:  IgG4-related disease; Metabolic tumour volume; Positron emission tomography with [18F]fluorodeoxyglucose; Tubarial glands

Mesh:

Substances:

Year:  2021        PMID: 34748155     DOI: 10.1007/s12149-021-01691-8

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  3 in total

1.  Risk factors of relapse following glucocorticoid tapering in IgG4-related disease.

Authors:  Takanori Sasaki; Mitsuhiro Akiyama; Yuko Kaneko; Hidekata Yasuoka; Katsuya Suzuki; Kunihiro Yamaoka; Tsutomu Takeuchi
Journal:  Clin Exp Rheumatol       Date:  2018-05-24       Impact factor: 4.473

2.  Independent Role of Nasal Congestion in Positive Airway Pressure Compliance for OSA Treatment.

Authors:  Hao Wu; Fang Fang; Yaxin Guo; Chan Wu; Yongxiang Wei
Journal:  Otolaryngol Head Neck Surg       Date:  2021-12-14       Impact factor: 5.591

3.  The Utility of Serum IgG4 Concentrations as a Biomarker.

Authors:  Shigeyuki Kawa; Tetsuya Ito; Takayuki Watanabe; Masahiro Maruyama; Hideaki Hamano; Masafumi Maruyama; Takashi Muraki; Norikazu Arakura
Journal:  Int J Rheumatol       Date:  2012-03-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.